CorrectSequence Therapeutics - LinkedIn
WEBCorrectSequence Therapeutics (Correctseq) is a clinical-stage biotech company employing its proprietary transformer base editing (tBE) technology to pioneer next-generation gene editing...
About Us-正序生物 - correctsequence.com
WEBCorrectSequence Therapeutics (Correctseq) is a clinical-stage biotech company employing its proprietary transformer Base Editor (tBE) to pioneer next-generation gene editing therapies. Our leading pipeline candidate, CS-101, utilizing innovative base editor targeting HBG , curing β-hemoglobinopathies , has obtained IND approval from the China ...
正序生物官网
WEB利用世界先进的碱基编辑体系，为罹患严重疾病的人们开发突破性精准碱基编辑疗法，造福人类健康。. 价值观. Value. 患者至上，勇担责任，. 精诚合作，开拓创新，. 追求卓越. 网站描述，一般显示在搜索引擎搜索结果中的描述文字，用于介绍网站，吸引浏览者 ...
CorrectSequence Therapeutics Correct the Gene Brighten the …
WEB2024-01-08. The World’s First Clinical Base Editing Therapy for Hemoglobinopathy. More. 2023-11-24. Cell Stem Cell | A novel strategy for treating β-hemoglobinopathy based on the transformer base editor (tBE) More. 2023-10-17. CorrectSequence Therapeutics to Participate in the 18th ASCAT Conference. More. Press Release. More. 2023-01-11.
CorrectSequence Therapeutics - Crunchbase Company Profile
WEBCorrectSequence Therapeutics is a clinical-stage biotech company for next-generation gene editing therapies.
CORRECTSEQUENCE THERAPEUTICS - Trademark Elite
WEBThis trademark application was filed with the USPTO (United States Patent and Trademark Office) under the trademark classification: Computer & Software Services & Scientific Services; Pharmaceutical Products; The CORRECTSEQUENCE THERAPEUTICS trademark application covers Pharmaceutical preparations for use in the treatment of diseases caused by ...
CorrectSequence Therapeutics Co., Ltd Trademarks
WEBJan 17, 2022 · Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations…. Owned by: CorrectSequence Therapeutics Co., Ltd. Serial Number: 97222592.
CORRECTSEQUENCE THERAPEUTICS Trademark of CorrectSequence Therapeutics ...
WEBCORRECTSEQUENCE THERAPEUTICS is a trademark and brand of CorrectSequence Therapeutics Co., Ltd, Shanghai CHINA. This trademark was filed to EUIPO on Friday, July 14, 2023.
CorrectSequence Therapeutics Receives Angel Round Investment …
WEBJun 13, 2023 · CorrectSequence Therapeutics (Correctseq), a pioneer gene editing biotechnology company, recently completed an angel round of financing of 40 million RMB (approximately USD 6 million). This...
CORRECTSEQ THERAPEUTICS Trademark of CorrectSequence Therapeutics …
WEBTrademark Serial Number is a unique ID to identify the CORRECTSEQ THERAPEUTICS mark in USPTO. The CORRECTSEQ THERAPEUTICS mark is filed in the category of Pharmaceuticals. The legal correspondent for CORRECTSEQ THERAPEUTICS trademark is NICHOLAS B. HAWKINS, WOMBLE BOND DICKINSON (US) LLP, 100 LIGHT STREET, 26TH FLOOR, BALTIMORE, MARYLAND UNITED ...
- Some results have been removed
Skip to content